Management of Cardiovascular Disease Risk Factors in Older Adults with Type 2 Diabetes Mellitus: 2002–2012 Literature Review

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of The American Geriatrics Society

• Publication date

  2013-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jgs.12513PMID 24219205PMCID PMC3978413
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

  2012cited by this paper
• Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes

  2012cited by this paper
• Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis.

  2012cited by this paper
• Long-term effects of intensive glucose lowering on cardiovascular outcomes.

  2011cited by this paper
• Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

  2011cited by this paper
• Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Diabetes: A Meta-Analysis

  2011cited by this paper
• Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

  2011cited by this paper
• Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

  2011cited by this paper
• Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

  2011cited by this paper
• Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials

  2011cited by this paper
• Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation

  2010cited by this paper
• Effects of intensive blood-pressure control in type 2 diabetes mellitus.

  2010cited by this paper
• Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.

  2010cited by this paper
• Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes

  2010cited by this paper
• Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial

  2010cited by this paper
• Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.

  2010cited by this paper
• Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial

  2010cited by this paper
• Effects of combination lipid therapy in type 2 diabetes mellitus.

  2010cited by this paper
• Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study

  2009cited by this paper
• Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials.

  2009cited by this paper
• Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.

  2009cited by this paper
• Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes

  2009cited by this paper
• Aspirin for the Primary Prevention of Cardiovascular Events

  2009cited by this paper
• Glucose control and vascular complications in veterans with type 2 diabetes.

  2009cited by this paper
• Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

  2009cited by this paper
• Intensive glucose control and macrovascular outcomes in type 2 diabetes

  2009cited by this paper
• Effects of Intensive Glucose Lowering in Type 2 Diabetes

  2009cited by this paper
• Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

  2009cited by this paper
• Long-term follow-up after tight control of blood pressure in type 2 diabetes.

  2008cited by this paper
• Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.

  2008cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.

  2008cited by this paper
• The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease

  2008cited by this paper
• MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals : a randomised placebo-controlled trial.

  2008cited by this paper
• asymptomatic peripheral arterial disease and antioxidants in patients with diabetes and randomised placebo controlled trial of aspirin factorial disease and diabetes (POPADAD) trial: The prevention of progression of arterial

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.

  2008influential reference
• Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes: The Treating to New Targets (TNT) study

  2008cited by this paper
• Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins

  2007cited by this paper
• Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

  2007cited by this paper
• Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial.

  2006cited by this paper
• A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women

  2006cited by this paper
• Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)

  2006cited by this paper
• Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes

  2006cited by this paper
• Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes

  2006cited by this paper
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes.

  2005cited by this paper
• Effects of estrogen with and without progestin on urinary incontinence

  2005cited by this paper
• Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

  2005cited by this paper
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

  2004cited by this paper
• Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

  2004influential reference
• Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus

  2004cited by this paper
• Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.

  2003cited by this paper
• MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

  2003cited by this paper
• Guidelines for improving the care of the older person with diabetes mellitus.

  2003cited by this paper
• Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study.

  2002cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

  2000cited by this paper
• Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study.

  1999cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk

  1998cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)

  1997cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators.

  1992cited by this paper
• Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

  1991cited by this paper
• Final report on the aspirin component of the ongoing Physicians' Health Study.

  1989cited by this paper
• Randomised trial of prophylactic daily aspirin in British male doctors

  1988cited by this paper

• Statin prescribing patterns in cardiovascular risk management among outpatients with type 2 diabetes: Real-world practices at a Vietnamese general hospital.

  2026cites this paper
• m6A demethylase FTO/ALKBH5 promotes diabetes-induced endothelial cell dysfunction by negatively regulating lncRNA H19.

  2025cites this paper
• Celebrating the Election of Dr Gerardo Moreno to the National Academy of Medicine

  2024cites this paper
• Risk factors predicting hospital length of stay in older patients with type 2 diabetes with Covid-19

  2022cites this paper
• Comparison of obesity indices and triglyceride glucose-related parameters to predict type 2 diabetes mellitus among normal-weight elderly in China

  2021cites this paper
• Management of Hyperglycemia in Older Adults with Type 2 Diabetes

  2021cites this paper
• Re-examining the Classification of Older Adults with Diabetes by Comorbidities and Relationship with Frailty, Disability, and 5-year Mortality.

  2021cites this paper
• Overexpression of microRNA-216a-3p Accelerates the Inflammatory Response in Cardiomyocytes in Type 2 Diabetes Mellitus by Targeting IFN-α2

  2020cites this paper
• Implementation of a Behavioral Economics Electronic Health Record (BE-EHR) Module to Reduce Overtreatment of Diabetes in Older Adults

  2020cites this paper
• Potentially inappropriate medications for older adults in a primary healthcare unit in southern Brazil

  2020cites this paper
• Interaction of Nuclear Receptor Subfamily 4 Group A Member 1 (Nr4a1) and Liver Linase B1 (LKB1) Mitigates Type 2 Diabetes Mellitus by Activating Monophosphate-Activated Protein Kinase (AMPK)/Sirtuin 1 (SIRT1) Axis and Inhibiting Nuclear Factor-kappa B (NF-κB) Activation

  2020cites this paper
• RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020

  2020cites this paper
• Cardiovascular disease risk prediction for people with type 2 diabetes in a population-based cohort and in electronic health record data

  2020cites this paper
• Assessing an Interprofessional Polypharmacy and Deprescribing Educational Intervention for Primary Care Post-graduate Trainees: a Quantitative and Qualitative Evaluation

  2019cites this paper
• Identify potentially inappropriate medications in older adults with chronic kidney disease and deprescribe when possible

  2019cites this paper
• Increased Dynamin‐Related Protein 1–Dependent Mitochondrial Fission Contributes to High‐Fat‐Diet‐Induced Cardiac Dysfunction and Insulin Resistance by Elevating Tafazzin in Mouse Hearts

  2019cites this paper
• Characteristics and prognosis of idiopathic sudden sensorineural hearing loss in aged people: a retrospective study

  2019cites this paper
• Multiple Antihyperglycemic Drug Use is Associated with Undernutrition Among Older Adults with Type 2 Diabetes Mellitus: A Cross-Sectional Study

  2019cites this paper
• Glycemic Control and Insulin Treatment Alter Fracture Risk in Older Men With Type 2 Diabetes Mellitus

  2019cites this paper
• Clinical guidelines for type 1 diabetes mellitus with an emphasis on older adults: an Executive Summary

  2019cites this paper
• Association between Diabetes and the Use of Removable Dental Prostheses among the Korean Population

  2019cites this paper
• High-Risk Prescriptions for Aging Patients

  2019cites this paper
• Identify potentially inappropriate medications in older adults with chronic kidney disease and deprescribe when possible

  2019cites this paper
• Diabetes mellitus and cardiovascular risk: Update of the recommendations of the Diabetes and Cardiovascular Disease working group of the Spanish Diabetes Society (SED, 2018).

  2018cites this paper
• Phlorizin Exerts Direct Protective Effects on Palmitic Acid (PA)-Induced Endothelial Dysfunction by Activating the PI3K/AKT/eNOS Signaling Pathway and Increasing the Levels of Nitric Oxide (NO)

  2018influential citation
• Diabetes mellitus and cardiovascular risk: Update of the recommendations of the Diabetes and Cardiovascular Disease working group of the Spanish Diabetes Society (SED, 2018).

  2018cites this paper
• Assessment of Drug Therapy Problems in Adult Patients With Both Cardiovascular Diseases and Type 2 Diabetes Mellitus at Kenyatta National Hospital

  2018cites this paper
• Relationship between glycemic control and perceived family support among people with type 2 diabetes mellitus seen in a rich kinship network in Southwest Nigeria

  2018cites this paper
• The Role of Deprescribing in Older Adults with Chronic Kidney Disease

  2018cites this paper
• HbA1c and hypoglycaemia in intensively treated type 2 diabetes: a retrospective cohort study in primary care

  2018cites this paper
• Interaction of Sulfonylureas with Liver Uptake Transporters OATP1B1 and OATP1B3

  2018cites this paper
• Trends in Diabetes Treatment and Monitoring among Medicare Beneficiaries

  2018cites this paper
• Diabetes in older people: position statement of The Hong Kong Geriatrics Society and the Hong Kong Society of Endocrinology, Metabolism and Reproduction.

  2017cites this paper
• Evidence-based recommendations and expert consensus on enteral nutrition in the adult patient with diabetes mellitus or hyperglycemia.

  2017cites this paper
• Hemoglobin A1c and Mortality in Older Adults With and Without Diabetes: Results From the National Health and Nutrition Examination Surveys (1988–2011)

  2017cites this paper
• Efficacy of Behavioral Interventions on Biological Outcomes for Cardiovascular Disease Risk Reduction among Latinos: a Review of the Literature

  2017cites this paper
• Intensive glycemic control in younger and older U.S. adults with type 2 diabetes.

  2017cites this paper
• Antihypertensive medicines utilization: A decade‐long nationwide study of octogenarians, nonagenarians and centenarians

  2017cites this paper
• Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

  2017cites this paper
• Overtreatment and Deintensification of Diabetic Therapy among Medicare Beneficiaries

  2017cites this paper
• Comparative Effectiveness for Glycemic Control in Older Adults with Diabetes

  2017cites this paper
• Effectiveness and safety of dipeptidyl peptidase 4 inhibitors in the management of type 2 diabetes in older adults: a systematic review and development of recommendations to reduce inappropriate prescribing

  2017cites this paper
• Management of Atherosclerotic Cardiovascular Disease Risk Factors in the Older Adult Patient With Diabetes

  2017cites this paper
• Depression and physical functioning among older Americans with diabesity: NHANES 2009–2010

  2017influential citation
• The impact of glycemic status on radiological manifestations of pulmonary tuberculosis in diabetic patients

  2017cites this paper
• Glycemic Control and Functional Decline in Nursing Home Residents With Diabetes

  2017cites this paper
• HYPERGLYCEMIA AND HYPOGLYCEMIA IN PATIENTS WITH DIABETES IN SKILLED NURSING FACILITIES.

  2017cites this paper
• Differential Diagnosis of Upper Extremity Ischemia

  2017cites this paper
• Glycemic Control and Functionality in Nursing Homes-More Than HbA1c-Reply.

  2017cites this paper
• Changes in Medication Use After Dementia Diagnosis in an Observational Cohort of Individuals with Diabetes Mellitus

  2017cites this paper
• Differential effects of pravastatin on the pharmacokinetics of paroxetine in normal and diabetic rats

  2017cites this paper
• Primary Care Practitioners' Views on Incorporating Long-term Prognosis in the Care of Older Adults.

  2016cites this paper
• A call for comparative effectiveness research to learn whether routine clinical care decisions can protect from dementia and cognitive decline

  2016cites this paper
• Precision medicine to precision care: managing multimorbidity.

  2016cites this paper
• Management of diabetes mellitus in older people with comorbidities

  2016cites this paper
• What Should Be the Target Blood Pressure in Elderly Patients With Diabetes?

  2016cites this paper
• Delivery of Care to Nursing Home Residents With Diabetes: Results From the SHELTER Study.

  2016cites this paper
• Diabetes treatment and hypoglycaemic episodes in elderly patients at nursing homes in Uppsala County

  2016cites this paper
• Patient-Centred Care of Older Adults With Cardiovascular Disease and Multiple Chronic Conditions.

  2016cites this paper
• Risk of hospitalization for hypoglycemia among older Korean people with diabetes mellitus

  2016cites this paper
• Applicability of the Spoken Knowledge in Low Literacy Patients with Diabetes in Brazilian elderly

  2016cites this paper
• Cognitive impairment and dependence of patients with diabetes older than 65 years old in an urban area (DERIVA study)

  2016cites this paper
• Treated glycosylated hemoglobin levels in individuals with diabetes mellitus vary little by health status

  2016cites this paper
• Acute effect of fast walking on postprandial blood glucose control in type 2 diabetes

  2016cites this paper
• Choosing wisely in case of hypertension, diabetes and hyperlipidemia in older patients

  2016cites this paper
• Mortality in Individuals Aged 80 and Older with Type 2 Diabetes Mellitus in Relation to Glycosylated Hemoglobin, Blood Pressure, and Total Cholesterol

  2016cites this paper
• Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study

  2015cites this paper
• Hypertension in the Young Adult

  2015cites this paper
• New Guidelines for Elderly Diabetic Patients

  2015cites this paper
• Prevalence of andRacialDisparities in Risk Factor Control in Older Adults With Diabetes : The Atherosclerosis Risk in Communities Study

  2015cites this paper
• Randomised controlled trial of the effectiveness of community group and home-based falls prevention exercise programmes on bone health in older people: the ProAct65+ bone study.

  2015cites this paper
• Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics

  2015cites this paper
• Glycemic Control in Older Adults With Diabetes Mellitus.

  2015cites this paper
• Effect of a patient decision aid (PDA) for type 2 diabetes on knowledge, decisional self-efficacy, and decisional conflict

  2015cites this paper
• Therapy of endocrine disease. Effects of chronic use of phosphodiesterase inhibitors on endothelial markers in type 2 diabetes mellitus: a meta-analysis.

  2015cites this paper
• Co-administration of paroxetine increased the systemic exposure of pravastatin in diabetic rats due to the decrease in liver distribution

  2015cites this paper
• Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database

  2015cites this paper
• Prevalence of and Racial Disparities in Risk Factor Control in Older Adults With Diabetes: The Atherosclerosis Risk in Communities Study

  2015cites this paper
• Antidiabetic and cardiovascular drug utilisation in patients diagnosed with type 2 diabetes mellitus over the age of 80 years: a population-based cohort study.

  2015cites this paper
• Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different Wards

  2015cites this paper
• Health Disparities in Cardiovascular Disease and High Blood Pressure Among Adults in Rural Underserved Communities

  2015cites this paper
• Reduction in self-monitoring of blood glucose in type 2 diabetes: an observational controlled study in east London.

  2015cites this paper
• Immunosenescence and vaccine failure in the elderly: strategies for improving response.

  2014cites this paper
• Cardiovascular disease in diabetes: are we doing enough?

  2014cites this paper
• Periodontitis in Cardiovascular Disease Patients with or without Marfan Syndrome -A Possible Role of Prevotella intermedia-

  2014cites this paper
• Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma.

  2014cites this paper
• Add-On Treatment with Teneligliptin Ameliorates Glucose Fluctuations and Improves Glycemic Control Index in Japanese Patients with Type 2 Diabetes on Insulin Therapy

  2014cites this paper
• In 85-year-old adults, MMSE predicted 5-year risk for first stroke better than Framingham score

  2014cites this paper
• Diabetes Mellitus, Physical Activity, and Longevity Between the Ages of 70 and 90

  2014cites this paper
• Predictors of urinary incontinence in community-dwelling frail older adults with diabetes mellitus in a cross-sectional study

  2014cites this paper
• Age-related differences in diabetes care outcomes in Korea: a retrospective cohort study

  2014cites this paper
• Digital Commons@Georgia Southern Digital Commons@Georgia Southern

  year unknowncites this paper